Evidence map›Paper›PMID 36093566›Full record

Trial reportJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2022

Long-Term Selenium-Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo-Controlled Trial.

Giorgia Perri, Tom R Hill, John C Mathers, Jennifer S Walsh, Fatma Gossiel, Kristian Winther, Jacob Frölich, Lars Folkestad, Søren Cold, Richard Eastell

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Giorgia PerriHuman Nutrition Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-3208-1197
Tom R HillHuman Nutrition Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
John C MathersHuman Nutrition Research Centre, Centre for Healthier Lives, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Jennifer S WalshDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Fatma GossielDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Kristian WintherDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.
Jacob FrölichDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.
Lars FolkestadDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.
Søren ColdDepartment of Oncology, Odense University Hospital, Odense, Denmark.
Richard EastellDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.ORCID 0000-0002-0323-3366
Newcastle University · GBOdense University Hospital · DKUniversity of Sheffield · GBUniversity of Southern Denmark · DK

Funding

Medical Research Council MR/K006312/1Medical Research Council MR/L016354/1Medical Research Council MR/P020941/1The MRC-Versus Arthritis Centre for Integrated Research into Musculoskeletal AgeingVersus Arthritis
6 · The paper itself

Abstract

Higher selenium status has been associated with lower bone turnover markers (BTM) in epidemiological studies. However, the long-term impact of selenium supplementation on BTMs has not been studied. We investigated the effects of selenium supplementation on BTMs including osteocalcin (OC), procollagen type I N-terminal propeptide (PINP), collagen type I cross-linked C-telopeptide (CTX), and bone alkaline phosphatase (BALP) in the short (6 months) and long term (5 years). A total of 481 Danish men and women (60-74 years) were randomized to receive placebo-yeast versus 100, 200, or 300 μg selenium as selenium-enriched yeast daily for 5 years. Plasma selenium concentration was measured using inductively coupled plasma mass spectrometry, and BTMs were measured in nonfasted samples at baseline, 6 months, and 5 years. Data were analyzed by ANCOVA to investigate the shape of the dose-response relationships. Covariates included age, body mass index, baseline selenium status, baseline BTM, smoking, alcohol, supplement use, and medication. Plasma selenium concentration (mean 86.5 μg/d at baseline) increased significantly with increasing selenium supplementation to 152.6, 209.1, and 253.7 μg/L after 6 months and remained elevated at 5 years (158.4, 222.4, and 275.9 μg/L for 100, 200, and 300 μg supplemental selenium/d, respectively (p < 0.001)). There was no change in plasma selenium concentration in the placebo-treated group. There was no significant effect of selenium supplementation on OC (6 months p = 0.37; 5 years p = 0.63), PINP (6 months p = 0.37; 5 years p = 0.79), CTX (6 months p = 0.91; 5 years p = 0.58) or BALP (6 months p = 0.17; 5 years p = 0.53). The relatively replete baseline selenium status in the study participants may explain this lack of effect. Testing in more deficient populations may provide further insights into the impact of selenium supplementation on bone health. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Indexed as

SeleniumAgedAlkaline PhosphataseBiomarkersBone RemodelingDietary SupplementsFemaleHumansMaleMiddle AgedOsteocalcinSaccharomyces cerevisiaeAlkaline PhosphataseBiomarkersOsteocalcinSeleniumBIOCHEMICAL MARKERS OF BONE TURNOVERGENERAL POPULATION STUDIESNUTRITION

Identifiers

PMID36093566
PMCPMC10087503
OpenAlexW4295235144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.